v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Assets:    
Cash and cash equivalents $ 9,542 $ 8,453
Investments 2,260 2,145
Accounts receivable, net 40,992 39,779
Inventories 17,770 19,246
Other current assets 4,253 5,091
Total current assets 74,817 74,714
Long-term investments 32,407 32,669
Property and equipment, net 13,037 13,083
Operating lease right-of-use assets 14,741 14,973
Goodwill 85,478 85,478
Intangible assets, net 25,070 25,508
Other assets 7,424 7,113
Total assets 252,974 253,538
Liabilities:    
Accounts payable 16,922 17,641
Pharmacy claims and discounts payable 26,149 26,344
Health care costs payable 15,518 15,399
Accrued expenses and other current liabilities 22,258 22,387
Other insurance liabilities 1,075 1,116
Current portion of operating lease liabilities 1,904 1,737
Current portion of long-term debt 2,580 4,068
Total current liabilities 86,406 88,692
Long-term operating lease liabilities 13,330 13,643
Long-term debt 60,531 60,502
Deferred income taxes 3,771 3,832
Other long-term insurance liabilities 4,592 4,716
Other long-term liabilities 6,707 6,771
Total liabilities 175,337 178,156
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,788 shares issued and 1,273 shares outstanding as of March 31, 2026 and 1,787 shares issued and 1,271 shares outstanding as of December 31, 2025 and capital surplus 50,679 50,402
Treasury stock, at cost: 515 and 516 shares as of March 31, 2026 and December 31, 2025 (36,706) (36,790)
Retained earnings 63,282 61,196
Accumulated other comprehensive income 201 406
Total CVS Health shareholders’ equity 77,456 75,214
Noncontrolling interests 181 168
Total shareholders’ equity 77,637 75,382
Total liabilities and shareholders’ equity $ 252,974 $ 253,538